N, S., IR, P., & KM, S. (2017). New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab. Dove Medical Press.
Cita Chicago Style (17a ed.)N, Seetharamu, Preeshagul IR, y Sullivan KM. New PD-L1 Inhibitors in Non-small Cell Lung Cancer – Impact of Atezolizumab. Dove Medical Press, 2017.
Cita MLA (8a ed.)N, Seetharamu, et al. New PD-L1 Inhibitors in Non-small Cell Lung Cancer – Impact of Atezolizumab. Dove Medical Press, 2017.
Precaución: Estas citas no son 100% exactas.